Flibanserin | search
Click here to view Flibanserin news from 60+ newspapers.
Bookmark or Share- Addyi® (flibanserin): HSDD Treatment for Certain Premenopausal WomenFRUSTRATED THAT YOU RARELY WANT SEX? It could be Hypoactive (low) Sexual Desire Disorder (HSDD). Fortunately, there’s a once-daily treatment known as Addyi, the FDA-Approved “LITTLE PINK PILL.” Learn more. Addyi is the #1 prescribed treatment for HSDD 1.
- Flibanserin (Oral Route) Side Effects - Mayo ClinicFlibanserin is used to treat hypoactive sexual desire disorder (HSDD) in women who have not gone through menopause. This medicine should only be used by women who have low sexual desire that is troubling to them and is not caused by a medical or mental problem, problems in the relationship, or medicine or other drug use.
- Flibanserin - WikipediaFlibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication improves sexual desire, increases the number of satisfying sexual events, and decreases the distress associated with low sexual desire.
- Flibanserin (Addyi): Uses, Interactions & Side Effects - Cleveland ClinicFLIBANSERIN (fly BAN ser in) is used to treat hypoactive (low) sexual desire disorder (HSDD) in women who have not gone through menopause, who have not had low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner.
- Flibanserin - StatPearls - NCBI BookshelfFlibanserin, initially developed as an antidepressant, is the first medication approved by the U.S. Food and Drug Administration (FDA) for the management of hypoactive sexual desire disorder (HSDD) in premenopausal women.
More
